















The Thesis Committee for Ran Hee Choi 
Certifies that this is the approved version of the following thesis: 
 
 















Roger P. Farrar 













Presented to the Faculty of the Graduate School of  
The University of Texas at Austin 
in Partial Fulfillment  
of the Requirements 
for the Degree of  
 
Master of Science in Kinesiology 
 
 






Above all, I am grateful to the almighty God for establishing me to complete this 
thesis. I wish to express my sincere thanks to my advisor, Dr. John Ivy, for his excellence 
guidance, caring and support. Without his guidance and persistent help, this thesis would 
not have been possible. I would like to thank Zhenping Ding for teaching me a lot of 
techniques and for providing me with his assist during my Master’s degree. I would also 
like to thank all my colleagues in Exercise Physiology and Metabolism Laboratory. I 
received generous support from them and I would never have been able to finish my 
thesis without them.  
Lastly, I would like to deeply thank my family for their support, encouragement, 






The effects of carbohydrate and HMB supplementation on glycogen 
synthesis post-exercise 
 
Ran Hee Choi, M.S.Kin. 
The University of Texas at Austin, 2013 
 
Supervisor:  Roger P. Farrar 
 
Carbohydrate plus additional protein supplementation provided immediately after 
exercise has been found to increase the rate of muscle glycogen restoration compared to 
carbohydrate alone. To examine whether leucine, and/or β-hydroxy-β-­‐methylbutyrate	  
(HMB)	   to	   carbohydrate	   plus	   protein	   supplementation	   affects	   short-­‐term	   recovery	  
(45	  min)	  of	  muscle	  glycogen,	  we	  compared	  plasma	  glucose	  and	  insulin,	  the	  muscle	  
glycogen	   concentration,	   and	   the	   cellular	   signaling	   proteins	   controlling	   muscle	  
glycogen	  synthesis	  45	  min	  after	  supplementation.	   	  
Rats	   (n=35)	   underwent	   high-­‐intensity	   resistance	   exercise	   followed	   by	  
supplementation	  with	   carbohydrate	   (CHO: 1.2g/kg body weight), carbohydrate with 
whey protein (CP: 1.2g CHO + 375mg whey protein/kg body weight), carbohydrate with 
whey protein plus HMB (CPH: 1.2g CHO + 375mg whey protein + 400mg HMB/kg 
body weight), carbohydrate with whey protein, HMB plus leucine (CPHL: 1.2g CHO + 
375mg whey protein + 400mg HMB + 444mg leucine/kg body weight) or exercise only 
(CON). Blood samples were collected immediately after exercise and 45 min after 
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supplementations. Muscle samples of plantaris were excised immediately and 45 min 
post-exercise. Plasma glucose was increased by CHO and CPH supplementation and 
reduced by CPHL at 45 min post-exercise. Plasma insulin was elevated by CP and CPHL 
treatments compare to CHO. Muscle glycogen concentration was unaffected by all 
treatments and did not differ from CON. Phosphorylation of Akt/PKB, GSK3α/β,	  and	  GS	  
at	  45	  min	  of	  recovery	  for	  all	  supplements	  was	  not	  significant	  difference	  from	  CON.	  
Phosphorylation	   of	   mTOR	   was	   significantly	   increased	   by	   CPHL	   and	   CP	  
supplementation	  compared	   to	  CON,	  CHO,	  and	  CPH.	  Phosphorylation	  of	  AS160	  was	  
markedly	  reduced	  by	  CPH	  supplementation	  compared	  to	  CON.	  These	  results	  suggest	  
that	  supplementing	  with	  carbohydrate	  plus	  protein	  with	  or	  without	  leucine	  and	  its	  
metabolite,	  HMB,	  to	  enhance	  muscle	  glycogen	  replenishment	  following	  exercise	  may	  
not	  provide	  an	  advantage	  during	  the	  early	  phase	  of	  recovery	  (45	  min).	  Furthermore,	  
there	   is	   some	   indication	   that	   HMB	   may	   elicit	   insulin	   resistance,	   and	   this	   needs	  
further	  evaluation.	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Muscle glycogen is a significant determinate of athletic performances. Utilization 
of intramuscular glycogen is tightly related to exercise intensity. For example, muscle 
glycogen will be quickly depleted when individuals perform exercise at higher intensity 
as opposed to lower exercise intensity. Consequently, the depletion of muscle glycogen 
leads to fatigue and impairs the athletes’ ability to perform. Therefore, fast recovery of 
intramuscular glycogen stores through nutritional supplements has received great 
attention as a strategy for athletes and physically active individuals in order to maintain 
and improve their physical performance and exercise training.  
The availability of glucose and insulin determine in large part the rate of muscle 
glycogen synthesis. Among the diverse nutrients that we consume through our daily 
meal, carbohydrate (CHO) is considered the primary nutrient to enhance the rate of 
muscle glycogen synthesis. CHO mainly supplies glucose, which compose the monomers 
that makes up glycogen, and stimulates the secretion of insulin. Ivy (1998) found that 
ingestion of 1.2 to 1.5 g of CHO /kg body weight could maximize the rate of muscle 
glycogen restoration when the supplement was provided immediately after exercise and 
then at 2-hour intervals for up to 6 hours post-exercise. 
Later research pointed out the importance of additional protein to a carbohydrate 
supplement for acceleration of muscle glycogen recovery. Although the mechanisms of 
additive protein have not clearly been identified, several studies showed that additional 
protein with carbohydrate supplement enhanced insulin secretion (Zawadzki et al. 1992, 
Berardi et al. 2006). Although Zawadzki et al. (1992) found that the addition of protein 
increased insulin secretion more than carbohydrate alone. Ivy et al. (2002) did not find a 
difference between carbohydrate plus protein and carbohydrate alone and insulin 
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response. However, carbohydrate and protein supplementation did result on a greater rate 
of glycogen synthesis. Therefore, it was suggested that additional protein might play a 
critical role in activation of enzymes regulating glycogen synthesis beyond the increase 
of insulin alone.  
In accordance with these findings, we hypothesized that different combinations of 
protein and their metabolites with carbohydrate would be more effective in activating key 
enzymes of cell signaling pathways controlling muscle glycogen synthesis than 
carbohydrate alone. We used whey protein, leucine, and β-hydroxyl-β-metylbutyrate 
(HMB), which is a metabolite of leucine. Whey protein is recognized as a high quality 
protein containing a rich source of branched-chain amino acids (BCAA). Moreover, 
carbohydrate supplementation with whey protein has been shown to increase the rate of 
muscle glycogen recovery in skeletal muscle (Morifuji et al. 2010). Leucine has also been 
demonstrated to positively potent promote glucose uptake under insulin-free conditions 
(Iwanaka et al. 2010, Doi et al. 2005, Nichitani et al. 2002).  These studies suggested 
that leucine increased glucose uptake through an insulin-independent pathway, possibly 
the mTOR signaling pathway. 
Although the effects of HMB supplementation on glycogen synthesis in skeletal 
muscle are unknown, HMB has been reported to prevent muscle damage and to preserve 
anabolic conditions after exercise. However, recent research suggests that it may cause 
insulin resistance (Gerlinger-Romero et al. 2011). Therefore, it becomes important to 
determine the effect of HMB in combination with carbohydrate and protein on glycogen 
recovery post-exercise.  
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Methodology 
ANIMAL CARE AND HOUSING 
Young male Sprague-Dawley rats (n=35), 2-3 months old, were obtained from 
Charles River Laboratories (Wilmington, MA). They were randomly housed 2 per cage in 
an animal facility kept at a constant temperature of 21°C and on a 12 h dark-light cycle 
schedule from 7:00 AM to 7:00 PM. They were fed standard laboratory chow (Prolab 
RMH 1800 5LL2, LabDiet, Brentwood, MO) and water ad libitum. Rats were allowed to 
acclimate to their environment once they arrived on campus. The Institutional Animal 
Care and Use Committee at The University of Texas at Austin approved all of the animal 
experiments and procedures.  
 
EXPERIMENTAL DESIGN 
There were 5 treatments groups (n=7) including a control group (CON) that was 
immediately sacrificed after exercise. After one week of acclimation, the rats were 
randomly separated into the 5 different groups according to their bodyweight, and then 
started a familiarization procedure. All treatment groups received different supplements 
after exercise except CON group. The treatment solutions consisted of 1) control (CON: 
sacrifice immediately after exercise with no treatment solution), 2) carbohydrate (CHO: 
1.2g/kg body weight), 3) carbohydrate with whey protein (CP: 1.2g CHO + 375mg whey 
protein/kg body weight), 4) carbohydrate with whey protein plus HMB (CPH: 1.2g CHO 
+ 375mg whey protein + 400mg HMB/kg body weight), 5) carbohydrate with whey 
protein, HMB plus leucine (CPHL: 1.2g CHO + 375mg whey protein + 400mg HMB + 
444mg leucine/kg body weight). Krebs-Henseleit Buffer (KHB) adjusted to a pH 7.4 was 
used to make all solutions. For supplying supplements, 4.5g of CHO (α-D-Glucose, 
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anhydrous 96%, ALDRICH, #14417TH), 1.41g of whey protein (SI03, Inc., Cape 
Girardeau, MO, U.S.A.), 1.88g of Ca(HMB)2 • H2O (Abbott Nutrition, Columbus, Ohio, 
U. S. A.), 1.67g of leucine (Ajinomoto, Fort Lee, NJ, U.S.A.) was added to 30ml of 
KHB. 8ml/kg body weight of treatment incubated through gavage.  
 
ANIMAL FAMILIARIZATION TO RESISTANCE EXERCISE 
For 2 weeks, all five groups of rats were familiarized with the ladder climbing 
protocol. Rats were trained three non-consecutive days a week. For the first week of 
training, the rats underwent three familiarization training sessions. Each session consisted 
of 4 climbs without weight attachment. The second week of training, proper weight (from 
50% to 70% of rat’s body weight) was attached to their tails. This weight was continually 
increased by 10% of body weight per each session. In addition, the number of repetitions 
(climbs) also incremented 8 times per session. Two-minute breaks were given between 
every climb. After the last familiarization session, the rats were given 2 days of rest 
before the experiment was started. 
 
EXPERIMENTAL PROTOCOL  
On the experimental day, the rats fasted for 12-14 hours and then climbed the 
ladder with the attachment, which consisted of 75% of their body weight attached to their 
tail. They went up the ladder 10 times and had a 2 minute break between climbs. Blood 
samples (0.5ml) were collected into a 1.5 ml test tube containing 50μl of EDTA 
(24mg/ml, pH 7.4) before the rats received treatment and after 45 minutes of incubation. 
The collected blood samples were placed on ice until centrifuged. After the first blood 
collection, all groups, except CON, received their respective supplement via gavage. 
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After 45 minutes, the second blood sample was taken. All blood samples were 
centrifuged at 4,000g for 15 minutes at 4°C and then stored at -80°C for plasma glucose 
and insulin analysis. Immediately after taking the second blood sample, the rats were 
anesthetized with an intraperitoneal injection of sodium pentobarbital (75mg/kg of body 
weight). Muscle samples of plantaris were collected. The muscle samples were frozen in 
liquid nitrogen, and stored at -80°C for later analysis. Right after all samples were 
collected, the rats were euthanized through a cardiac injection of sodium pentobarbital 
(65mg/kg of body weight). 
 
PLASMA GLUCOSE ANALYSIS 
Plasma glucose was determined by using a glucose color reagent kit (Raichem, 
San Diego, CA). following the manufacture’s instruction, 10μl plasma samples were put 
into tubes containing 1.5ml of reagent. After 10 min of incubation at 37°C, all samples 
were visualized at wavelength of 500 nm by a Beckman DU 640 spectrophotometer.  
 
PLASMA INSULIN ANALYSIS 
A commercially available radioimmunoassay (RIA) kit (Linco Research St, 
Charles, MO) was used to measure plasma insulin following the manufacture’s 
instructions. 125I-labeled rat insulin was delivered to the tubes containing standards, 
controls, or plasma samples. The tubes were incubated overnight at 4°C. All samples 
measured on a Wallac 1470 WizardTM automatic gamma counter (Pekin Elmer life 




MUSCLE GLYCOGEN ANALYSIS 
Muscle glycogen was determined by the method described by Passonneau and 
Lauderdale (1974).  Around 80mg of muscle was digested in 1N KOH at 65-70°C for 
30 min. After muscle digestion, 100μl of the homogenates were added to tubes 
containing 250μl of 0.3 mol/L sodium acetate buffer (pH4.8). Next, additional 10μl of 
50% glacial acetic acid and 250μl of 0.3 mol/L sodium acetate buffer containing 
10mg/ml amyloglucosidase were delivered to the tubes.  All tubes were incubated 
overnight at room temperature. After overnight incubation, 25μl of 1N NaOH  were put 
to the sample tubes for neutralization. Glucose concentration was measured by using a 
glucose color reagent (Raichem, San Diego, CA). 
 
MUSCLE HOMOGENIZATION 
Frozen muscle samples (80-100μg) were homogenized in ice-cold 
homogenization buffer (consisting of 20mM EGTA 50mM NaF, 100mM KCl, 0.2mM 
EDTA, 50mM glycerophosphate, 1mM DTT, 0.1mM PMSF, 1mM Benzamidine, 0.5mM 
Na Vanadate) with a glass tissue pestle (Corning Life Science, Acton MA). The muscle 
homogenates were centrifuged at 13,000g for 15minutes at 4°C. The centrifuged samples 
were stored at -80°C for later analyses after aliquoting the homogenate into several 
microfuge tubes. Protein quantification of muscle samples was measured through a 
modification of the Lowry protein assay method (Lowry et al. 1951). 
 
WESTERN BLOTTING 
Western blots were run to determine the phosphorylation state of Akt/PKB, 
mTOR, AS160, GS, and GSK3α/β. α-tubulin was measured as an internal control. 
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Homogenized muscle samples (100μl) were diluted with an equal amount (1:1) of 
Laemmli buffer (1.25M Tris, 20% glycerol, 4% SDS, 0.02% bromophenol blue, 10% β-
meraptoethanol, pH 6.8) and denatured at 95°C for 10 minutes. For all blots wells were 
loaded with 60μg protein. The western blots were run on 10% gels of sodium dodecyl 
sulfate polyacrylamide for 90 minutes at 130V. After completion of electrophoresis, 
resolved muscle proteins were transferred to a nitrocellulose membrane at 90V for 90 
minutes. The transfer membranes were blocked in 7% non-fat dry milk dissolved in Tris-
Tween 20 buffered saline (TTBS) for 30 minutes at room temperature (RT). Next, the 
blocked membranes were washed 3 times with TTBS for 5 minutes and then incubated 
overnight with either phosphor-Akt/PKBSer473, anti-phospho-mTORSer2448, anti-
phospho AS160Thr642, anti-phospho-GSSer641, anti-phospho-GSK3α/βSer21/9, or 
anti- α-tubulin (Cell Signaling Technology, Inc., Danvers, MA) at 4°C. All primary 
antibodies were prepared 1:1000 with 2% non-fat dry milk dissolved in TTBS.  
After an overnight incubation, species-specific (anti-rabbit) immunoglobulin G 
(IgG) secondary antibodies (Cell Signaling Technology, Inc., Danvers, MA) were applied 
to the membranes for 1 hour at RT following 3 times washing for 5 minutes each time. 
The secondary antibodies were diluted to 1:1000 in 2% non-fat milk TTBS.  After 
membrane washing, the proteins were detected by a ChemoDoc ECL detection system 
and quantified by Quantity One software in accordance to the manufacturer’s instructions 
(Bio-Rad, Hercules, CA).  
 
STATISTICAL ANALYSIS 
 All muscle data were analyzed by a one-way ANOVA.  A two-way repeated 
ANOVA was performed on plasma glucose and insulin data. All statistical results were 
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confirmed using PASW v20.0 software (PASW Inc., Chicago, IL) and significance was 




A total of 35 rats were involved in the present study. Body weight of each group 
was CON 402.43 ± 11.74g; CHO 401.86 ± 7.01g; CP 409.29 ± 7.58g; CPH 392.86 ± 
8.22g; CPHL 403.71 ± 5.85g. There were no significant differences among groups in 
regard of body weight.  
 
PLASMA GLUCOSE LEVEL 
The results for plasma glucose level are shown in Fig. 1. There were no 
differences in plasma glucose, immediately after exercise among all groups. There were 
significant differences among groups at 45 min after receiving treatment. CHO and CPH 
treatments elevated plasma glucose 45ming after supplementation.  In contrast, plasma 
glucose significantly decreased at 45 min after supplementation with CPHL (Fig. 1A). 
Moreover, the glucose area under the curve (AUC) was significantly decreased with the 
CPHL treatment, but increased with CHO, CP, and CPH treatment (Fig. 1B).  
 
PLASMA INSULIN LEVEL 
The level of plasma insulin is illustrated in Fig 2. Plasma insulin level 
immediately after exercise showed no difference among treatment groups. After 45min of 
supplementation, all treatments raised the plasma insulin level (Fig. 2A). CPHL 
significantly increased the plasma insulin level compared to CHO. CP also elevated the 
plasma insulin level relative to CHO at 45 min post supplementation. There was no 
significant difference in insulin AUC among all treatment groups (Fig. 2B) 
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MUSCLE GLYCOGEN CONCENTRATION  
Fig. 3 shows the concentration of muscle glycogen post-exercise after 45 min of 
supplementation. There was no significant difference among treatment groups observed. 
Nor did any of the treatment groups differ from CON. 
 
MUSCLE PROTEIN SIGNALING RESPONSES 
 
Phosphorylation of Akt/PKB (Ser473) 
Phosphorylation of Akt/PKBSer473 (Fig. 4) following supplementation was not 
different from CON and there was no treatment effect. 
Phosphorylation of mTOR (Ser2448) 
mTOR phosphorylation was markedly increased 45 min post CPHL 
supplementation compared to CON, CHO and CPH supplementation in plantaris muscle 
(Fig. 5). In addition, CP significantly enhanced mTOR phosphorylation compared to 
CHO.  
Phosphorylation of AS160 (Thr642) 
AS160 phosphorylation was considerably decreased after 45 min post CPH 
supplementation compared to CON (immediately after exercise) (Fig. 6).  Furthermore, 
phosphorylation of AS160 showed a tendency to be reduced by CPHL treatment below 
CON, but this difference was not significant. 
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Phosphorylation of GSK3 α/β (Ser21/9) 
Neither GSK α or β phosphorylation was statistical difference from CON at 45 
min following post-exercise treatment in plantaris muscles (Fig. 7). Furthermore, there 
were no significant differences among treatments. 
 Phosphorylation of GS (Ser641) 
GS phosphorylation was unaffected by the treatments 45 min after 
supplementations in plantaris muscle (Fig. 8). 
Abundance of total α-tubulin  
Total α-tubulin was measured as an internal control protein. As shown Fig. 9, α-
tubulin did not show any statistical differences across treatments, which suggests equal 







Figure 1. (A) Plasma glucose immediately after exercise, and 45 min post 
supplementation. Values are means ±SE. *, p<0.05 CPHL vs. all other treatments at the 
same time point. (B) Plasma glucose AUC. Values are means ±SE. *, p<0.05 vs. CHO. $, 






Figure 2. (A) Plasma insulin immediately after exercise, and 45 min post 
supplementations. *, p<0.05 CHO vs. CPHL at 45 min. $, p<0.05 CHO vs. CP at 45 min. 
(B) Plasma insulin AUC. Values are means ±SE.  
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Figure 3. Muscle glycogen concentration 45 min after each treatment. Values are 
expressed means ±SE. No significant difference was detected. 
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Figure 4. Plantaris AktSer473 phosphorylation 45 min after each treatment. Values are 
means ±SE.  
 
Figure 5. Plantaris mTORSer2448 phosphorylation 45 min after each treatment. Values are 
means ±SE. *, p<0.05 vs. CON. $, p<0.05 vs. CHO. #, p<0.05 vs. CPH 
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Figure 6. . Plantaris AS160Thr642 phosphorylation 45min after each treatment. Values are 






Figure 7. Plantaris GSK3 (A) αSer21 and (B) βSer9 phosphorylation 45 min after each 
treatment. . Values are means ±SE. 
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Figure 8. Plantaris GSSer641 phosphorylation 45 min after each treatment. Values are 
means ±SE. 
 
Figure 9. Total protein abundance of α-tubulin in plantaris was used to evaluate the 
amount of protein equally loaded. Values are expressed as means ±SE.  
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Discussion 
In the present study, carbohydrate alone or carbohydrate with additional protein 
and its metabolites supplementations provided immediately after exercise changed 
plasma glucose and insulin levels. Nevertheless, they did not affect muscle glycogen 
replenishment during 45 min of recovery. In addition, the phosphorylation status of cell 
signaling proteins controlling muscle glycogen synthesis, such as Akt/PKB, GSK3 α/β, 
and GS, did not show a significant difference among all treatments compared to CON. 
However, CPHL supplementation enhanced the phosphorylation of mTOR compared to 
CON, CHO, and CPH supplementation during the 45 min recovery period. CP treatment 
also increased the phosphorylation of mTOR more than CHO alone. In addition, CPH 
supplementation reduced the phosphorylation of AS160 compared to CON during early 
recovery. 
The availability of glucose and insulin post-exercise is considered a primary 
stimulus for muscle glycogen resynthesis. Both factors are able to accelerate glucose 
uptake not only by the translocation of GLUT 4 (Kuo et al. 1999) but also by the 
activation of anabolic signaling pathways (Bak et al. 1991). In the present study, CP and 
CPHL supplementations greatly promoted the secretion of insulin over CHO alone at 45 
min post-exercise. Zawadzki et al. (1992) reported that carbohydrate plus protein 
treatment improved the rate of muscle glycogen synthesis during 4-h recovery via 
increasing insulin secretion caused by additional protein. However, several investigators 
criticized this study. Because the supplements were not isoenergetic, higher calorie count 
could possibly accounted for the elevated insulin level after carbohydrate plus protein 
supplemention.  In a more recent study by van Loon et al. (2000) similar results to 
Zawadzki et al. (1992) was found even though they compared isocaloric treatments 
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between carbohydrate (1.2 g carbohydratekg-­‐1h-­‐1)	   alone and carbohydrate (0.8 g 
carbohydratekg-­‐1h-­‐1) plus protein (0.4 g proteinkg-­‐1h-­‐1).  In our study, we observed 
a remarkable increase in the level of insulin during 45 min post-exercise recovery after 
ingestion of CP and CPHL compared with CHO alone. However, these results did not 
result in an increased muscle glycogen concentration in this early recovery period. This 
discrepancy is probably caused by a high-amount of carbohydrate (1.2 g 
carbohydratekg-­‐1h-­‐1) that we used. The study from van Hall et al. (2000) demonstrated 
that carbohydrate plus protein supplement did not amplify leg glucose uptake compared 
to carbohydrate alone even though the insulin level was increased by carbohydrate plus 
protein supplement. This study suggested that effects of elevated insulin had no benefit 
when carbohydrate was provided at rates of 1.0 g carbohydratekg-­‐1h-­‐1.	  Additionally, 
Jentjens et al. (2001) reported that additional protein to a high-amount of carbohydrate 
(1.2 g carbohydratekg-1h-1) supplementation did not result in a further increase in the 
rate of muscle glycogen replenishment. Taken together the results of our present study 
and the other studies (van Hall et al. 2000, Jentjens et al. 2001) imply that the availability 
of protein and its effect on muscle glycogen synthesis post exercise may be related to the 
amount of glucose made available.	   	  
The present study showed that CHO and CPH treatments increased the level of 
plasma glucose compared to CP and CPHL during the 45 min post-exercise period.  
Although we assumed that abundant glucose availability after exercise is crucial for 
promoting glycogen resynthesis, our results did not affirm this idea.  The recovery 
period around 30-60min post-exercise is known as an insulin-independent glycogen 
synthetic phase. This phase is mainly controlled by exercise-induced GLUT 4 
translocation (Thorell et al. 1999) and insulin is not required. Similar to the results of 
Hara et al. (2011), the present study did not find any differences in the muscle glycogen 
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concentration at 45 min after all treatment groups. However, Hara et al. (2011) observed 
a significant improvement of muscle glycogen at 90min after ingestion. These results 
suggest that nutritional supplementation could be beneficial in an insulin-dependent 
phase, which begins at least after 1-h post-exercise, but not in the insulin-independent 
phase. 
With regard to the activation of cell signaling proteins regulating muscle glycogen 
synthesis, CPHL and CP treatments strongly improved the phosphorylation of mTOR 
relative to CON, CHO, and CPH, respectively. The mTOR pathway can independently 
activate glucose transport.  Phosphorylated mTOR subsequently activates p70S6K, 
which is one of its down stream substrates. p70S6K is then able to inactivate GSK3 by 
phosphorylation, which leads to the activation of GS by dephosphorylation (Sutherland et 
al. 1993, Armstrong et al. 2001). Although CPHL and CP supplementation induced 
mTOR phosphorylation, there were no significant difference detected in the 
phosphorylation of GSK3 α/β and GS. Hara et al. (2011) also showed no effects of GSK 
α/β at 30 min post-exercise supplementation compared to control group.  However, they 
observed a significant difference in the dephosphorylation of GS after 30 min post-
exercise supplementation compared to a control group.  This difference in	   results may 
be related to the different exercise modes, exercise intensities, and durations of exercise 
used to deplete the muscle glycogen stores.  Hara et al. (2011) used a strenuous 3-h 
swimming program, whereas in the current study a resistance exercise challenge was 
used.  
Leucine is a popular branched-chain amino acid because it can directly stimulate 
mTOR phosphorylation. In addition, leucine could have benefits to improve glucose 
uptake after exercise via the activation of mTOR/p70S6K (Iwanaka et al. 2010) or PI3K 
and PKC pathways (Nichitani et al. 2002). In the present study, we cannot determine if 
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leucine improved glucose uptake because we provided leucine in combination 
supplement ingredients and had no direct measure of rate of glucose uptake. Although 
there was no marker of glucose uptake, we assessed the phosphorylation of AS160, 
which provides an indirect measure of the activation of GLUT 4. After 45 min post 
CPHL supplementation, AS160 phosphorylation was reduced below CON, but this 
reduction was not significant. Future work is needed to clarify if leucine is involved in 
suppressing AS160 phosphorylation by CPHL supplementation or if other ingredients in 
the supplement are involved such as HMB.  
HMB is a metabolite of leucine, and it has been reported that HMB actively 
inhibits protein degradation in skeletal muscle when the body goes through catabolic 
stresses, including cancer and AIDS (Wilson et al. 2008). Furthermore, HMB is 
considered a recovery agent following high intensity or prolonged exercise (Nissen et al. 
1996, Wilson et al. 2009). The relationship between HMB and muscle glycogen 
replenishment has received less attention. In the present study, acute HMB combined 
with carbohydrate, whey protein, with or without leucine treatment did not affect muscle 
glycogen concentration during 45 min of post-exercise recovery. However, CPH group 
significantly reduced the phosphorylation of AS160 compared to CON at 45 min post 
supplementation. This result might relate to the findings of Vukovich et al. (2001) and 
Gerlinger-Romero et al. (2011).  
Vukonich et al. (2001) determined that HMB kinetics peaked within 60-120 min 
whether 1g or 3g of HMB was consumed with or without glucose. Moreover, this study 
demonstrated that ingestion of HMB plus glucose could delay peak HMB metabolism 
relative to HMB alone. This study might suggest that we need to set a longer time point 
of at least over 60 min in order to observe any effects of HMB.  
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Another possibility comes from the study of Gerlinger-Romero et al. (2011) 
indicating that chronic HMB supplementation for 4 weeks study evoked insulin 
resistance. Although in the present study CPH supplementation tended to increase plasma 
glucose relative to CHO supplementation even both group showed the plasma insulin 
response, the difference did not reach significance. Although we cannot conclude that 
acute HMB causes insulin resistance, it would be of interest to examine how HMB 
combined with carbohydrate supplementation affects glucose and insulin metabolism and 
its effects on glycogen synthesis. 
In conclusion, our results demonstrated that combinations of carbohydrate and 
additional protein and its metabolites did not affect muscle glycogen replenishment at a 
very early recovery period (45 min post-exercise) although some of our treatments did 
increase insulin secretion above CHO alone. These results suggest that post-exercise 
nutritional supplementation may not significantly affect muscle glycogen restoration 
during the insulin-independent phase (after 30-60 min post-exercise) of glucose uptake. 
Therefore, future research should evaluate the effect of these treatments over a longer 
recovery time period of at least after 90 min. Furthermore, it would be important to assess 
the various combination of whey protein, leucine, and/or HMB with or without 
carbohydrate supplements in order to determine the effect of each metabolite on cellular 




Muscle glycogen is an essential fuel of athletic performances. This fuel source is 
mainly utilized at moderate- to high-intensity exercise. When the amount of muscle 
glycogen is lowered, athletes or people who enjoy exercise will not continue their 
performance because of fatigue. In addition, high muscle glycogen storage has been 
shown to improve training quality. Therefore, researchers have focused on muscle 
glycogen restoration by nutritional supplements as an effective strategy in order to 
promote performance among athletic or physically active populations. 
In the past, endurance types of exercise were conducted to study muscle glycogen 
depletion. These types of exercise are easily controlled to reach 70-80% of VO2max, which 
is an intensity that progressively uses muscle glycogen for energy generation. However, 
recent studies have identified that intensive resistance exercise actively utilizes muscle 
glycogen when exercising at 70-75% of one repetition maximum. Accordingly, the 
depletion of muscle glycogen by resistive exercise training has become an important 
issue that has to be resolved for professional athletes and active populations. The reason 
is that a fast recovery will improve the quality of performance at next bout of exercise. 
Hence, this review will demonstrate resistive training significantly lowers muscle 
glycogen as endurance training does, and then will consider why muscle glycogen 
recovery is a key factor of exercise.  
Nutritional supplements are a primary strategy to replenish muscle glycogen after 
exercise.  Most important considerations are what nutrients should be consumed and 
how they work in the human body in order to accelerate and enhance muscle glycogen 
recovery. Therefore, this review will first give information about major signaling 
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pathways, which involve the restoration of muscle glycogen. Moreover, information of 
nutrients that have been shown to greatly effect the anabolic muscle condition will be 
provided. 
  
GLYCOGEN AS FUEL  
Glucose and glycogen are major forms of carbohydrate in the human body and act 
as primary energy sources during exercise. Their utilizations become an important issue 
with rising exercise intensity. During low-intensity aerobic exercise, which is around less 
than 30% of VO2max, carbohydrate oxidation takes 10-15% of total energy expenditure. 
Furthermore, the largest portion of carbohydrate oxidation comes from plasma glucose 
with little breakdown of intramuscular glycogen store. However, glycogen utilization 
dynamically increases to 70-80% of energy production during high-intensity exercise of 
around 80% of VO2max (Romijn et al. 1993, Hollozy and Kohrt 1996).  
As exercise intensity keeps rising, muscle glycogen progressively becomes an 
important energy fuel, and its stored amount in skeletal muscle seems to be a determinant 
of athletic performance. Hargreaves and Richter (1988) reported that low muscle 
glycogen storage might result in a deleterious performance at high and moderate intensity 
exercise. Therefore, they recommended a carbohydrate-rich diet regimen in the pre-
exercise period in order to accumulate intramuscular glycogen storage. The importance of 
muscle glycogen has been a growing issue in terms of athletic performance because of 
the evidence that elevated muscle glycogen supports strenuous exercise. Therefore, there 
has been increased interest in muscle glycogen supercompensation regimen, in which 
carbohydrate feeding after a glycogen-depleting exercise increases muscle glycogen 
concentration above the individual basal level (Bergström and Hultman, 1966).  
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The focus of muscle glycogen research has moved from preparation before 
training and competition to replenishment after training and competition. Recently, the 
research of muscle glycogen has investigated the most effective ways of restoring the 
muscle glycogen within several hours after exercise or between bouts of exercise. The 
depletion of intramuscular glycogen results in impaired performance at moderate to high 
intensity exercise (Coyle et al. 1986, Hermansen et al.1965). This problem addresses the 
necessity of the fast and short-term muscle glycogen recovery in order for the return of 
performance capacity.  
 
COMPONENTS INVOLVED IN GLYCOGEN REPLENISHMENT 
The investigations of the short-term recovery of muscle glycogen have been 
mainly focused on timing (Ivy et al. 1988a, Levenhagen et al. 2001), the amount of 
supplementation (Ivy et al. 1988b, Ivy 1998) and type of supplementation to ingest 
(Burke et al. 1993, Van Loon et al. 2000, Zawadzki et al. 1992). Recent research 
(Levenhagen et al. 2001) was concentrated on the rate of leg glucose uptake with a 
carbohydrate-protein supplement, which was provided immediately after or 3 hours after 
exercise. The rate of leg glucose uptake was roughly 3-fold greater than basal when 
consumption was immediate, at the immediate consumption, while the 3-hour delayed 
consumption showed only a 44% increase above basal. Moreover, the studies from Ivy 
(1998a and 1998) found that immediate ingestion of carbohydrate after exercise 
promoted muscle glycogen resynthesis more rapidly than delayed ingestion (Ivy et al. 
1998a). They also found 1.2 to 1.5gkg-1 body wt of carbohydrate supplemented at 2-hour 
intervals (Ivy 1998) maximized muscle glycogen storage. 
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With regard to type of supplement, several studies have found that the 
combination of carbohydrate with a small amount of protein enhances insulin secretion 
and glycogen synthesis immediately post-exercise. Although the study of Zawadzki et al. 
(1992) had a limitation, as the research team did not consider the difference in calories 
between carbohydrate and carbohydrate-protein supplements, they reported the 
possibility that ingestion of carbohydrate-protein immediately post-exercise promotes a 
greater insulin response and muscle glycogen resynthesis than carbohydrate alone. Later 
research (Ivy et al. 2002, Berardi et al. 2006) suggested a practical approach for short-
term muscle glycogen recovery: that a moderate amount of carbohydrate plus a small 
amount of protein improves muscle glycogen synthesis as much as a high amount of 
carbohydrate and is effective in reducing the gastric burden caused by large boluses of 
carbohydrate.  
 
RESISTANCE EXERCISE AND MUSCLE GLYCOGEN UTILIZATION 
Research about glycolytic energy metabolism and its resynthesis has 
predominantly focused on prolonged exercise rather than resistance exercise. This 
phenomenon is caused by the thought that resistance exercise mainly uses the 
phosphagen fuels, such as ATP and phosphocreatine, with negligible muscle 
glycogenolysis.  However, recent research has revealed that high-intensity weight 
bearing exercise also utilizes both the phosphagen fuels and muscle glycogen almost 
immediately the same as endurance exercise (Goldfarb et al. 1989, Tesch et al.1986). 
Although evaluation of muscle energy metabolism on weight lifting is limited, several 
studies have reported that muscle glycogen is a significant energy source following high-
intensity resistive exercise and it should be restored after exercise. Muscle glycogen 
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restoration between bouts may be an important strategy for athletes in order to improve 
their muscular performance.  
Robergs et al. (1991) compared the glycogen depletion following two different 
intensities of resistance exercise, 75% one repetition maximum (1RM) and 35% 1RM, 
and the rate of glycogen repletion without supplement after 2 hours post-exercise. In this 
study, total muscle force development was the same between 75% 1RM with low 
repetition and 35% 1RM with high repetition. High- and low- intensity resistance 
exercise showed similar amounts of muscle glycogenolysis to endurance exercise. This 
finding proved that muscle glycogen utilization of intensive resistance exercise also 
depends on exercise intensity. Interestingly, the rate of muscle glycogenesis without any 
supplement was 11.1±3.4 and 7.2±1.3 mmolkg wet wt-1h-1 in 70% 1RM and 30% 1RM, 
respectively. This is a greater rate of muscle glycogen synthesis than has typically been 
shown following endurance exercise when supplementation is provided (Ivy et al. 1988). 
Although there was no difference in the rate of muscle glycogen recovery with or without 
supplementation, it is widely known that glucose uptake and muscle glycogen resynthesis 
is promoted by the availability of glucose and insulin (Ahlborg and Felig, 1976, 
Maehlum et al. 1978).  Therefore, supplying with carbohydrate or carbohydrate plus 
additional protein after exercise increases the level of glucose and insulin and strongly 
stimulates muscle glycogen repletion.  
Other studies with various post-exercise supplementations have reported faster 
rates of muscle glycogen recovery. The research from Pascoe et al. (1993) used 
carbohydrate (1.5gkg-1) and the same volume of water as a placebo after repetitive 70% 
1RM knee extension. This study demonstrated that repetitive high-intensity resistance 
exercise utilized muscle glycogen as a major fuel source, which was depleted around 
30% from the basal level. Post-exercise feeding with carbohydrate enhanced the rate of 
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muscle glycogen restoration better than feeding with water. After 6 hours of recovery, the 
amount of recovered muscle glycogen in the carbohydrate ingestion trial was significant 
and reached 91% of pre-exercise level. 
Another study conducted high-intensity resistance exercise with trained subjects 
and compared carbohydrate alone and isocaloric supplements containing carbohydrate, 
protein and fat. The study observed plasma insulin and glucose and the rate of muscle 
glycogen resynthesis (Roy et al. 1998). They found similar patterns of plasma insulin and 
glucose in both supplements. In addition, there was no difference in the rate of muscle 
glycogen repletion by both supplements and the rate was similar to the results of 
Zawadzki et al. (1992), which supplied carbohydrate combined with protein supplement 
after endurance exercise. These findings also demonstrate that resistance exercise 
significantly utilizes muscle glycogen as an energy source and the total amount of 
carbohydrate and energy in a supplement is a critical determinant of the muscle glycogen 
repletion.  Their carbohydrate alone supplement also showed much greater the rate of 
muscle glycogen resynthesis than that of the previous study (Pascoe et al. 1993). This 
difference may be due to the training status of the subjects. Roy et al. (1988) recruited 
highly trained subjects, and it has been demonstrated that highly trained people such as 
athletes have higher insulin sensitivity and glucose transporter-4 (GLUT4) content 
compared with those who are untrained (Ebiling et al. 1993). Thus, enhanced insulin 




MECHANISMS OF GLYCOGEN SYNTHESIS AFTER EXERCISE 
In the post-exercise period, a sufficient level of substrate, glucose, must be 
supplied for muscle glycogen recovery. Glucose uptake after exercise is an important first 
process to restore muscle glycogen. Insulin and substrate availability influence this 
process. GLUT4 is extensively located in skeletal muscle and insulin normally controls 
its function. When insulin binds to its receptor, GLUT4 is translocated from an 
intracellular space to the cell membrane for glucose uptake. Moreover, exercise is able to 
stimulate the translocation of GLUT4 and is referred to as the insulin-independent 
pathway (Thorell et al. 1999). It has been suggested that both stimuli, such as insulin and 
muscle contraction, have additional benefits for the translocation of GLUT4 in the 
muscle (Lund et al. 1995). The translocation of GLUT4, in response to insulin and 
muscle contraction may be a crucial determinant of the maximal rate of muscle glycogen 
replenishment because it supplies sufficient sources of glucose for building muscle 
glycogen. 
Rebuilding muscle glycogen, particularly after exercise, consists of two phases: 
the rapid and slow phases. The rapid phase is also called the insulin-independent phase 
because this phase can initiate glycogen storage without insulin. Generally, the rapid 
phase only persists between 30-60 minutes.  This phase solely occurrs when the level of 
muscle glycogen falls below a certain level, which is 128-150 mmol/kg dw (Price et al. 
1994).  Glycogen synthase (GS) is considered a rate-limiting factor in glycogen 
synthesis. Although GS is primarily stimulated by insulin, it has been demonstrated that 
there is an insulin-independent way to increase GS activity, which explains a tight 
relationship between the concentration of muscle glycogen and the activity of GS 
(Nielsen and Wojtaszewski, 2004). For instance, if the concentration of muscle glycogen 
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lowers after exercise, then GS will become an active form and initiates re-building of 
muscle glycogen in the skeletal muscle.  
The slow phase is also called the insulin-dependent phase. It has been shown that 
muscle glycogen synthesis in the slow phase is related to increased sensitivity of insulin 
and muscle glucose uptake. Exercise enhances insulin sensitivity and its status can last 
over 48 hours depending on carbohydrate supplement and the degree of muscle glycogen 
(Cartee et al. 1989). Increased insulin sensitivity promotes GLUT4 activity and results in 
increased muscle glucose uptake. Moreover, insulin-stimulated muscle glucose uptake 
with a low abundance of muscle glycogen is controlled by activation of protein kinase B 
(PKB), which is also known as Akt.  
Insulin, which is a typical anabolic hormone in the body, strongly mediates 
muscle glycogen synthesis in part due to its stimulating effect on muscle glucose uptake. 
In addition, insulin regulates enzymes controlling muscle glycogen synthesis through 
phosphorylation. After insulin binds to its receptor, a signal that activates 
phosphatidylinositol 3-kinase (PI3K) occurs and then this signal subsequently 
phosphorylates Akt/PKB. Phosphorylated Akt/PKB stimulates GLUT4 translocation in 
response to phosphorylation of AS160, which is recognized as an important signal 
protein involved in control of GLUT4 translocation (Frosig et al. 2007). Additionally, 
Akt/PKB regulates GS activity in response to inhibition of glycogen synthase kinase-3 
(GSK3) (Cross et al. 1995).  
Akt substrate of 160kDa, known as AS160, has been proposed as a significant 
signaling protein for regulation of GLUT4 traffic to the plasma membrane. This 
translocation is induced not only by insulin but also by muscle contraction (Sakamoto 
and Holman, 2008). For instance, the study from Kramer et al. (2006) using mouse 
tibialis anterior skeletal muscle found that overexpression of AS160-4p reduced the rate 
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of insulin-dependent glucose uptake (~30%) and of contraction-dependent glucose uptake 
(~40%) as well. This study suggested that AS160 was a significant factor in controlling 
glucose uptake. Furthermore, GSK3 plays a crucial role in regulation of GS in skeletal 
muscle (MacAulay et al. 2005). To stimulate glycogen synthesis requires 
dephosphorylation of GS. The activation of GS is mainly controlled by the inhibition of 
GSK3 activity induced by insulin signaling (Suzuki et al. 2001). When GSK3 is 
phosphorylated by insulin, this inactivates the enzyme and allows activation of GS by 
dephosphorylation. 	  
The	   mammalian	   target	   of	   rapamycin	   (mTOR)	   is	   another	   target	   protein	   of	  
Akt/PKB.	  This	  is	  a	  key	  protein	  kinase	  that	  regulates	  protein	  synthesis	  by	  nutrients,	  
such	   as	   amino	   acids,	   in	   skeletal	   muscle.	   Phosphorylated	   mTOR	   activates	   its	  
downstream	   proteins	   including	   eukaryotic	   initiation	   factor	   4E	   binding	   protein-­‐1	  
(4E-­‐BP1)	  and	  ribosomal	  protein	  S6	  kinase	  (p70S6K)	  (Dennis	  et	  al.	  1999).	  It	  has	  been	  
reported	  that	  p70S6K	  is	  powerfully	  involved	  in	  the	  inactivation	  of	  GSK3,	  which	  can	  
lead	  to	  an	  increase	  in	  muscle	  glycogen	  synthesis	  (Sutherland	  et	  al.	  1993).	   	  
 
POST-EXERCISE NUTRITIONAL SUPPLEMENTS 
Exercise can result in the depletion of energy source such as glycogen within a 
few hours. The rate of muscle glycogen restoration mainly determines the time of 
recovery for next-bout of exercise or training. The amount of available substrate in the 
body after exercise plays a pivotal role in determining the rate of muscle glycogen 
recovery. Especially, professional athletes or active individuals who perform high-
intensity training with short breaks between exercise bouts need a quick recovery. 
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Therefore, the consumption of nutritional supplements, typically containing carbohydrate 
and protein, is a predominant strategy for fast recovery in the active population.  
Carbohydrate (CHO) supplementation is a major provider of glucose and 
stimulation of insulin secretion, which are determinants of the rate of muscle glucose 
uptake. In addition, they assist in building muscle glycogen. Therefore, CHO is highly 
recommended as a powerful supplement after exercise. Several studies have investigated 
adequate amounts of CHO for optimizing the rate of muscle glycogen synthesis. The 
initial study from Ivy et al. (1988) did not observe differences in the rate of glycogen 
restoration between two doses of CHO consumption, 0.75 or 1.5 g carbohydratekg-1h-1, 
supplied at 2-h intervals. A subsequent study by Ivy (1998) suggested consuming 1.2 to 
1.5 gkg-1	   of CHO at 2-h intervals for the purpose of maximally increasing glycogen 
synthesis. Additionally, this study proposed that more frequent provision of supplements 
could improve the optimal rate of glycogen storage (Ivy et al. 1998). Later, van Loon et 
al. (2000) supported this idea that more frequent supplements could accelerate the 
resynthesis of muscle glycogen at 30-min intervals.  
As mentioned above, adequate glucose and insulin availability post-exercise are 
prime regulators to increase the activation of glucose transport (Kuo et al. 1999) and 
glycogen synthase (Bak et al. 1991). Moreover, recent studies have reported that 
ingestion of amino acids with carbohydrates could be beneficial in maximizing the 
anabolic effect of exercise. The mechanisms of additive anabolic function by amino acids 
ingestion still remains to be found. However, several researchers have argued that the 
change in insulin responses is a potential mechanism. Amplified insulin secretion could 
have a great anabolic effect on the body (Fryburg et al. 1995, Hillier et al. 1998). 
Therefore, combined supplement with carbohydrate and amino acids has been 
recommended for short-term and fast muscle glycogen replenishment (Hara et al. 2011, 
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Ivy et al. 2002. van Loon et al. 2000, Zawadzki et al. 1992).  For example, Zawadzki et 
al. (1992) compared the rate of muscle glycogen synthesis for a 4-hr interval between two 
supplements, which were carbohydrate (CHO) and carbohydrate plus protein (C+P).  
This study demonstrated that C+P enhanced the level of plasma insulin leading to a great 
rate of glycogen synthesis. However, the increased insulin response may have been 
caused by the higher calorie content of the C plus P supplement compared with the CHO 
supplement. Further studies that employed isoenergetic CHO and C plus P supplements, 
such as Ivy et al. (2002) and Hara et al. (2011), have shown that the addition of protein to 
a carbohydrate supplement promotes muscle glycogen synthesis, although this was not 
occurred with a greater insulin response. These studies suggest that insulin may not be a 
major factor increasing the rate of glycogen synthesis with additional protein. Additional 
protein may play a crucial role in the activation of enzymes regulating glycogen 
synthesis, including Akt/PKB and/or GS.  
 
SYNERGETIC EFFECTS OF LEUCINE ON GLYCOGEN SYNTHESIS 
Branched-chain amino acids (BCAA), especially leucine, are generally known as 
strong insulinotropic amino acids, and they are frequently added into post-exercise 
supplements with CHO in order to maximize an insulin secretion. Leucine has been 
demonstrated to stimulate insulin sensitivity (Zanchi et al. 2012) and anabolic effects 
through insulin-dependent and/or –independent pathways (Anthony et al. 2000). 
Enhancing insulin secretion and sensitivity, resulting from leucine and/or additional 
amino acids intake, is likely to accelerate post-exercise muscle glycogen restoration. 
Leucine directly activates mTOR, which is a major insulin-independent pathway. In 
addition, activated mTOR phosphorylates its down stream protein, p70S6K, which is 
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involved in the inhibition of GSK3, leading to the activation of GS by dephosphorylation 
(Sutherland	  et	  al.	  1993).	  
The	   effects	   of	   leucine	   on	   insulin-­‐stimulated	   glucose	   uptake	   have	   been	  
doubted	  for	  a	  long	  time	  (Nichitani	  et	  al.	  2002,	  Doi	  et	  al.	  2005).	  However,	  Iwanwaka	  
et	  al.	  (2010)	  provided	  evidence	  that	  leucine	  could	  improve	  contraction-­‐induced,	  but	  
not	  insulin-­‐stimulated,	  glucose	  uptake	  (Iwanaka	  et	  al.	  2010).	  They	  suggest	  possible	  
mechanisms	   that	   enhance	   contraction-­‐induced	   and	   attenuate	   insulin-­‐induced	  
glucose	   transport.	   According	   to	   the	   results,	   leucine	   directly	   activated	   the	  
mTOR/p70S6K	   pathway	   in	   both	   glucose	   transport	   pathways.	   However,	   leucine	  
promoted	  contraction-­‐induced	  glucose	  transport	  via	  activation	  of	  5’-­‐AMP-­‐activated	  
protein	  kinase	  (AMPK),	  which	  is	  a	  sensor	  of	  energy	  status	  and	  is	  involved	  in	  insulin-­‐
independent	   glucose	   transport.	   This	   activation	   of	   AMPK	   was	   abolished	   by	  
rapamycin,	   which	   is	   a	   specific	   inhibitor	   of	   mTOR/p70S6K.	   Compared	   with	  
contraction-­‐stimulated	   glucose	   transport,	   insulin-­‐stimulated	   transport	   was	  
attenuated	  by	   leucine	  administration	  via	   the	   inhibitory	  phosphorylation	  of	   insulin	  
receptor	  substrate	  1	  (IRS	  1).	   It	  was	  also	  diminished	  by	  rapamycin.	  Although	  these	  
results	  suggest	  the	  opposite	  effects	  of	  leucine	  on	  glucose	  transport,	  the	  mechanisms	  
have	   not	   yet	   been	   identified.	   Thus,	   the	   increase	   in	   the	   rate	   of	   muscle	   glycogen	  
synthesis	  at	  post-­‐exercise	  by	  administration	  of	  leucine	  could	  be	  positively	  expected	  
with	   improved	  anabolic	  conditions	  via	   their	   insulinotropic	  character	  and	  ability	   to	  
phosphorylate	  mTOR/p70S6K.	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Β-­‐HYDROXYL-Β-­‐METYLBUTYRATE (HMB) AS A SUPPLEMENT 	  
β-­‐hydroxyl-β-­‐metylbutyrate (HMB) is a metabolite derived from leucine. Leucine 
is metabolized into α-ketoisocaproate (KIC) and then KIC has two ways to convert into 
HMB: 1) it directly converts into HMB in the cytosol by α-ketoisocaproate dioxygenase 
and, 2) it becomes isovaleryl-CoA in the mitochondria by α-ketoacid dehydrogenase 
before being HMB. Under normal conditions, KIC takes the later pathway to become 
HMB, therefore only 5% of leucine is converted into HMB (Zanchi et al. 2011). 600g of 
high quality protein contain approximately 60g of leucine. Thus, this enormous amount 
has to be consumed in order to make 3g of HMB, which is the recommended daily 
amount (Wilson et al. 2008). Since this assumption is impractical, intake of HMB as a 
supplement has become popular. Moreover, any adverse effects, such as liver or renal 
failure, have not been reported with 3 – 6g/day of HMB. 
Anti-catabolic property is the most well known function of HMB. Thus, the 
studies of HMB supplements are largely divided into two parts; one is related to sports 
performance, such as resistance or endurance training, another is about therapeutic 
aspects of HMB which includes clinical conditions, such as cancer, AIDS, and chronic 
renal failure. The common character of both parts is that skeletal muscle receives extreme 
stress that can cause proteolysis and muscle wasting. According to the study of Nissen et 
al. (1996), intake of 3.0g/day of HMB with resistance training for 3 weeks blunted the 
increase of muscle damage markers, creatine phosphokinase (CPK) and lactate 
dehydrogenase (LDH). The other studies of HMB (Gallagher et al. 2000a, Panton et al. 
2000) also reported a reduction in the indicator of muscle damage and an increase in 
muscle mass with 3.0g/day of HMB. Several studies have proposed therapeutic effects of 
HMB. Consumption of HMB with leucine to cancer patients who suffer cachexia 
improved muscle wasting syndromes (Smith et al. 2005). This positive result may be due 
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to combined functions with HMB and leucine. HMB could diminish muscle protein 
degradation while leucine could enhance protein synthesis. Furthermore, HMB lowered 
tumor growth in tumor-bearing animal studies (Caperuto et al. 2007, Nunes et al. 2008). 
Although these prevalent properties of HMB have been reported, there is still a lack of 
studies on aspects of HMB and muscle glycogen recovery.  
Most HMB studies have concentrated on the regulation of muscle protein balance. 
However, the mechanisms on the protein balance still remains to be determined. Based 
on the studies that revealed possible pathways to increase muscle protein condition, HMB 
may enhance muscle glycogen restoration following two possible mechanisms: 1) 
Insulin-like growth factor 1 (IGF-1) gene expression in skeletal muscle and 2) mTOR 
signaling pathway. Kormasio et al. (2009) reported that cultured cells incubated with 
HMB expressed IGF-1 nearly twofold more than control cells. IGF-1 is known as a 
potent activator of Akt/PKB through phosphorylation of PI3K pathway. An activated 
Akt/PKB leads to the initiation of mTOR pathways, including 4E-BP1 and p70S6K 
(Bodine et al. 2001).  Furthermore, Eley et al. (2007) observed that incubated skeletal 
muscle cells with HMB significantly enhanced protein synthesis via the activation of 
mTOR pathways and its down stream proteins. Although HMB studies have only focused 
on muscle protein synthesis and degradation, HMB may assist in recover of muscle 




The rate of muscle glycogen recovery after exercise determines the performance 
quality of the next bout of exercise or training. Insulin and substrate availability are 
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significant factors that influence glucose uptake for muscle glycogen restoration. 
Carbohydrate is the first consideration as a fuel source for a post-exercise supplement, 
because it provides glucose and increases insulin secretion. Additional protein sources, 
such as whey protein and leucine, with carbohydrate have been shown to have a positive 
effect on muscle glycogen restoration. These effects may be caused by the insulinotropic 
property of protein. In addition, protein could regulate enzymes controlling muscle 
glycogen synthesis such as Akt/PKB, AS160, GS, and GSK3, but the mechanisms have 
not been elucidated.  
A metabolite of leucine, HMB, has not been seriously considered as a supplement 
for muscle glycogen replenishment. However, it has anti-catabolic function under severe 
stressful conditions, including high-intensity exercise and cancer. Furthermore, potential 
actions on cellular signaling pathways induced by HMB supplementation suggest it could 
promote muscle glycogen restoration.  
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APPENDIX A: Glucose Assay 
 
1. Prepare a color reagent (Raichem, 80038, 100mg) and dissolve it with 100ml 
ddH2O  
2. Set up 12x75mm test tubes and label them as blank, standards, and plasma sample 
in duplicate 
3. Pipette 1.5ml reagent into the each test tube  
4. Pipette 20μl of each standard (50mg/dl, 100mg/dl, 150mg/dl, 200mg/d) into tubes 
in order to make standard curve 
5. Add 20μl of plasma samples into corresponding tubes 
6. Cover the test tubes with parafilm 
7. Incubate the tubes in water bath for 10min at 37°C 
8. Turn on the spectrophotometer and set up the wavelength at 500nm 
9. After 10min incubation, measure the samples at 500nm 
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APPENDIX B: Rat Insulin Assay 
 
Day one: 
1. Dilute all plasma samples at 1:1 dilution using assay buffer 
2. Add 200μl of assay buffer to the non-specific binding (NSB) tubes and 100μl to 
the reference tubes 
3. Add 100μl of standards, samples, or controls to 12x75mm glass assay tubes in 
duplicate and then add 100μl of hydrated 125I-Insulin to the tubes 
4. Add 100μl of rat insulin antibody to all tubes except blank tubes  
5. Vortex them and incubate overnight at 4°C after covering the tubes with parafilm 
 
Day two: 
1. Add 1ml of cold precipitating reagent to all tubes except blank tubes and NSC 
tubes 
2. Vortex and incubate 20min at 4°C 
3. Centrifuge the tubes except blank tubes and drain all tubes for 60sec 
4. Count each tube for 2min using gamma counter and determine the concentration 
based on the standard curve 
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APPENDIX C: Muscle Glycogen Assay 
 
Prepare stock solutions: 
1N KOH (200ml) 
Chemical Amount (g) FW. 
KOH 11.22 56.11 
1) Add 11.22g of KOH into 180ml ddH2O and bring to 200ml with ddH2O 
1N NaOH 
Chemical Amount (g) FW. 
NaOH 8 40 
1) Add 8g of NaOH into 180ml ddH2O and bring to 200ml with ddH2O 
0.3M Sodium Acetate, pH4.8 (500ml) 
Chemical Amount (g) FW. 
Sodium acetate 12.3 82.03 
1) Add 12.3g of sodium acetate into 450ml ddH2O, stir well, and  bring to 500ml with 
ddH2O 
2) Adjust pH to 4.8 with HCl 
50% Glacial Acetic Acid (200ml) 
Chemical Amount (ml) 
Glacial Acetic Acid 100 
1) Add 100ml of glacial acetic acid into 100ml ddH2O and mix well 
 
Muscle glycogen assay procedure: 
Day one 
1. Turn on water bath and set to 65-70°C 
2. Cut frozen muscle samples around 50-100mg and put into a glass tube containing 
1ml 1N KOH 
3. Cover the tubes with marbles and incubate at 65-70°C, while shaking, for 20min 
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4. During 20min incubation, prepare the amyloglucosidase mixture with 0.3M 
sodium acetate, pH4.8 (0.3M sodium acetate contains 10mg/ml of enzyme) and 
the enzyme must be put on ice 
5. After 20min incubation, vortex the tubes vigorously and incubate for an additional 
10min 
6. Transfer 100μl of homogenate to glass tubes with 250μl of 0.3M sodium acetate, 
pH4.8 and then vortex 
7. Add 10μl of 50% glacial acetic acid to the tubes 
8. Add 250μl of 0.3M sodium acetate, pH4.8, which contained 10mg/ml 
amyloglucosidase and then vortex well 
9. Seal the tubes with parafilm and incubate overnight at RT 
 
 Day two 
1. Turn on water bath to set at 37°C  
2. Prepare Raichem glucose color reagent according to manufacture’s instruction 
3. Make standards (18.02mg/dl, 9.01mg/dl) 
4. Add 25μl of 1N NaOH to the incubated test tubes for neutralization 
5. Follow the glucose assay procedure provided by the manufacture  
6. Read absorbance of samples at 500nm wavelength using the spectrophotometer 
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APPENDIX D: Lowery Protein Assay 
1. Prepare samples on ice and standards using 5mg/ml bovine serum albumin 
(BSA) stock following below: 
 1) Label duplicate 12x75mm glass assay tubes of each standard and sample 
1. 2. Dilute muscle samples with ddH2O in 1:30 ratio. 
2. Make solution A 
1) Add 48ml of 2% sodium carbonate (20g/L of 0. 1 NaOH) to a 125ml flask  
2) Add 1ml of 1% cupric sulfate and 1ml of 2% sodium potassium tartate to the 
flask 
3) Mix them well 
3. Add 0.1ml of standards or samples to the glass tubes 
4. Add 1.0ml of Solution A to each tube and incubate for 10min at RT after 
vortex the tubes 
5. Dilute phenol reagent with ddH2O in 1:2 ratio 
6. After 10min incubation, add 0.1ml of the reagent into each glass tube while 
vortexing the glass tube and then incubate for 30min at RT 
7. Turn on the spectrophotometer and let the bulb warm up at wavelength of 
750nm.  
8. Measure the standards and samples  
  Water (ml) Protein (ml) Protein cont. (mg/ml) 
Blank 1.0 0 0 
A 1.8 0.2 of stock 0.5 
B 0.2 0.8 of A 0.4 
C 0.5 0.5 of B 0.2 
D 0.5 0.5 of C 0.1 
E 0.5 0.5 of D 0.05 
F 0.5 0.5 of E 0.025 
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APPENDIX E: Muscle Homogenization 
 
Muscle Homogenization buffer (100ml, pH7.4) 
Reagent Concentration (mM) Amount (g) 
HEPES 20 0.477 
EGTA 2 0.076 
NaF 50 0.209 
KCl 100 0.746 
EDTA 0.2 0.0074 
β-Glycerophosphate 50 1.08 
DTT 1 0.015 
PMSF 0.1 0.00174 
Benzamidine 1 0.0157 
Sodium vanadate 0.5 0.0092 
 
1. Add all reagents to 80ml ddH2O, and then adjust pH to 7.4. 
2. Bring the volume to 100ml ddH2O and stir it on a magnetic plate.  
3. Store the homogenization buffer at -20°C 
 
Muscle Homogenization procedure: 
1. Weight around 80-100mg of muscle samples 
2. Dilute the muscle samples to 1:8 in the homogenization buffer. 
3. Homogenize the muscle with a glass tissue grinder pestle at 3000rpm by an 
electrically powered stirrer. 
4. Centrifuge muscle samples at 13,000g for 10 min at 4°C 
5. Aliquot and store the supematants at -80°C for further analyze  
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APPENDIX F: Western Blot 
Solution preparation: 
0.25% Bromophenol Blue Dye 
Chemical Amount (g) 
Bromophenol Bule 0.0125 
1. Add 0.0125g Bromophenol Blue into 5ml ddH2O 
2. Vortex until dissolved and store at room temperature (RT) 
2X Laemmli Sample Buffer (50ml) 
Chemical Amount (ml) 
1.25M Tris-HCl (pH6.8) 5 
Glycerol 10 
20% SDS 5 
β-Mercaptoethanol 2.25 
0.25% Bromophenol Blue 1.6 
1. Add all chemicals into 40ml ddH2O 
2. Stir well until dissolved and bring the volume to 50ml with ddH2O 
3. Store it at RT 




1. Add all chemicals to 150ml ddH2O 
2. Stir well until dissolved on a magnetic plate and bring to 200ml with ddH2O 





10% Ammonium persulfate (2ml) 
Chemical Amount (g) 
Ammonium persulfate 0.2 
1. Add this chemical to 2ml ddH2O and vortex until dissolved (prepare daily fresh) 
1.5M Tris Buffer, pH8.8 (500ml) 
Chemical Amount (g) 
Trisbase 90.82 
1. Add 90.82g of Trisbase into 400ml ddH2O and stir it on a magnetic plate 
2. Bring to 500ml volume with ddH2O 
3. Adjust pH to 8.8 and store at 4°C 
1.0M Tris Buffer, pH6.8 (500ml) 
Chemical Amount (g) 
Trisbase 60.57 
1. Add 60.57g of Trisbase into 400ml ddH2O and stir it on a magnetic plate 
2. Bring to 500ml volume with ddH2O 
3. Adjust pH to 8.8 and store at 4°C 
10% Filtered Sodium Dodecyl Sulfate (SDS) (100ml) 
Chemical Amount (g) 
Sodium dodecyl sulfate 10 
1. Add the chemical to 80ml ddH2O and stir it on a magnetic plate 
2. Bring to 100ml volume with ddH2O  
3. Filter the solution with Whatman #1 filter paper and store it at RT 
20% Filtered Sodium Dodecyl Sulfate (SDS) (100ml) 
Chemical Amount (g) 
Sodium dodecycl sulfate 20 
1. Add the chemical to 80ml ddH2O and stir it on a magnetic plate 
2. Bring to 100ml volume with ddH2O  
3. Filter the solution with Whatman #1 filter paper and store it at RT 
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10X Western Blot Running Buffer (2L) 
Chemical Amount (g) 
Trisbase 60.56 
Glycine 288.4 
Sodium dodecycl sulfate 20 
1. Add all reagents listed above into 1.5L ddH2O  
2. Stir well until dissolved on a magnetic plate 
3. Bring the volume to 2L with ddH2O and store at RT 
10X Tris-Tween Buffered Saline (TTBS), pH7.4 (2L) 
Chemical Amount (g) 
Trisbase 24.2 
NaCl 175.36 
Tween 20 12ml 
1. Add all chemicals listed above into 1.5L ddH2O 
2. Stir well until dissolved on a magnetic plate and bring to 2L with ddH2O 
3. Adjust pH to 7.4 
0.1% Reversible Ponceau S. Dye (50ml) 
Chemical Amount (g) 
Dye-Ponceau S 0.05 
Acetic Acid 2.5ml 
1. Add 0.05g of Dye-Ponceau S and 2.5ml of Acetic acid into 45ml ddH2O 
2. Vortex well until dissolved and bring to 50ml with ddH2O  







Western Blot Transfer Buffer (2L) 
Chemical Amount (g) 
Glycine 28.8 
Trisbase 6.04 
Methanol 300ml (15%) 
Sodium dodecycl sulfate 0.75 
1. Add all chemicals into 1.4L ddH2O and stir well until dissolved on a magnetic plate 
2. Bring to 2L with ddH2O and store it at RT 
 
Western Blot Procedure: 
1. Make resolving gel solution (10% resolving gel for 2 gels)  
Chemical Amount (ml) 
ddH2O 4 
Acrylamide mix 3.3 
1.5M Tris buffer, pH8.8 2.5 
20% SDS 0.1 
10% APS 0.1 
TEMED 0.004 
1) Add all chemicals listed above into 50ml test tube. 
2) Mix them and fill 3/4 caster with the resolving gel solution (around 4.5ml/gel) 
3) Put 200μl butanol on the resolving gel and allow 30 min for the gel to polymerize 
4) After gel polymerized, pour butanol and smoothly wash the caster with ddH2O  
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2. Make stacking gel solution (for 2 gels) 
Chemical Amount (ml) 
ddH2O 3.4 
Acrylamide mix 0.83 
1.0M Tris buffer, pH8.8 0.63 
20% SDS 0.05 
10% APS 0.05 
TEMED 0.005 
1) Add all chemicals listed above into 15ml test tube and well mixed 
2) Fill the caster with stacking gel solution then put combs into place 
3) Allow 30min for stacking gel to polymerize 
3. Prepare samples  
1) Take the samples out of -80°C and thaw them on ice 
2) Dilute the samples to 1:2 with sample buffer in the microfuge tubes 
3) Vortex and place in 90-95°C water for 10min  
4. Prepare 1X Running buffer 
1) Add 100ml 10X Running buffer into 900ml ddH2O and stir on a magnetic plate 
5. Remove the combs and assemble gel apparatus and then fill inner and out 
chamber with 1X Running buffer 
6. Load 10μl of standard, 12-20μl of the samples, or 10μl of molecular weight 
marker to corresponded gel lane 
7. Electrophoresis at 130V for 1h 30min 
8. After the electrophoresis, prepare for wet-transfer buffer described as above 
9. Cut 9*6cm rectangle Nitric Cellular Membranes and label them 
10. Carefully separate casing plates, remove the stacking gel, and place the resolving 
gel in the wet-transfer buffer for 5min 
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11. Assemble the transfer sandwich cassette in the transfer buffer according to the 
orders: black platespongy padfilter paperthe resolving gelthe 
membranefilter paperspongy padclear plate 
12. Electrophoresis at 90V for 1h 30min 
13. During the transfer, prepare 1X TTBS 
1) Add 100ml 10X TTBS into 900ml ddH2O and stir on a magnetic plate 
14. Prepare 7% non-fat dry milk (NFDM) (30ml/membrane) 
1) Add 4.2g NFDM into a 100ml beaker containing 60ml 1X TTBS and stir it on a 
magnetic plate 
15. After transfer, dissemble the sandwich, stain each membrane with Ponceau S. for 
5 sec, and then put membrane into 1X TTBS on a shaker to wash out Ponceau S. 
on the membrane 
16. Put the washed membrane into a container with 7% NFDM for 20min with gently 
shaking 
17. During blocking, prepare primary antibody with 2% NFDM  
18. After blocking, wash three times for 5min with 1X TTBS 
19. Incubate the membrane with the primary antibody overnight at 4°C with gently 
shaking 
20. After overnight incubation, wash 3x5min with 1X TTBS 
21. Incubate the membrane with secondary antibody for 1h at RT with gently shaking 
22. After secondary incubation, wash 3x5min with 1X TTBS 
23. Visualize protein bands using an ECL detection kit and Bio-Rad ChemiDoc 
detection system following the manufacturer’s instructions 
24. Quantify the density of the bands using Quantity One Analysis software 
 
 51 
APPENDIX G: Modified Krebs-Henseleit Bicarbonate (KHB) Buffer 
 
Modified Krebs-Henseleit Bicarbonate (KHB) Buffer-stock solutions 
1. Add all chemicals listed above into 400ml ddH2O and stir well until dissolved on 
a magnetic plate 
2. Bring to 500ml with ddH2O and store it at 4°C 
 
1. Add all chemicals listed above into 400ml ddH2O and stir well until dissolved on 
a magnetic plate 
2. Bring to 500ml with ddH2O and store it at 4°C 
 
Make 500ml of KHB buffer: 
1. Mix 50ml of Stock 1 with 380ml ddH2O 
2. Add 50ml of Stock 2 into Stock 1 solution and adjust pH to 7.4 
3. Bring to 500ml with ddH2O 
Stock 1: 10X (500ml) 
  Chemical Final Cont. Amount (g) FW. 
NaCl 1.16M 33.895 58.44 
KCl 46mM 1.7145 74.56 
KH2PO4 11.6mM 0.789 136.1 
NaHCO3 253mM 10.625 84.01 
Stock 2: 10X (500ml) 
  Chemical Final Cont. Amount (g) FW. 
CaCl22H2O 25mM 1.8375 147 
MgSO47H2O 11.6mM 1.4295 246.48 
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APPENDIX H: Raw Data 
# of rats Treatment 0min (mM) 45min (mM) AUC (mMx45min) 
5 CON 7.43   
16 CON 3.92   
22 CON 7.55   
26 CON 6.64   
28 CON 9.90   
34 CON 8.31   
39 CON 8.89   
2 CHO 6.95 7.39 9.81 
3 CHO 6.49 7.60 25.00 
13 CHO 6.80 7.87 24.11 
15 CHO 8.56 8.14 -9.51 
29 CHO 7.66 8.29 14.34 
33 CHO 7.99 8.21 4.95 
35 CHO 7.77 9.56 40.25 
4 CP 8.87 9.00 2.93 
14 CP 7.92 8.37 10.13 
21 CP 7.57 7.63 1.46 
24 CP 7.99 7.43 -12.44 
31 CP 7.97 7.67 -6.74 
32 CP 7.00 8.15 25.89 
38 CP 7.75 7.20 -12.28 
6 CPH 5.55 8.11 57.61 
17 CPH 9.39 8.26 -25.35 
19 CPH 7.95 8.17 4.95 
20 CPH 6.55 8.33 40.09 
23 CPH 8.12 8.39 5.87 
30 CPH 7.04 9.18 48.35 
36 CPH 7.38 9.39 45.18 
1 CPHL 8.81 7.67 -25.85 
10 CPHL 7.55 6.76 -17.66 
18 CPHL 7.56 7.41 -3.29 
25 CPHL 7.03 6.27 -17.05 
27 CPHL 8.72 7.54 -26.69 
37 CPHL 7.65 7.72 1.46 




# of rats Treatment 0min (pM) 45min (pM) AUC (pMx45min) 
5 CON 147.38     
16 CON       
22 CON 247.59     
26 CON 257.58     
28 CON 545.80     
34 CON 406.68     
39 CON 381.20     
2 CHO 268.60 318.18 1115.70 
3 CHO 95.04 250.69 3502.07 
13 CHO 172.18 308.54 3068.18 
15 CHO 224.52 272.38 1076.96 
29 CHO 77.82 288.91 4749.48 
33 CHO 215.56 431.47 4857.95 
35 CHO 273.76 468.32 4377.58 
4 CP 318.18 726.24 9181.30 
14 CP 462.47 515.84 1200.93 
21 CP 205.23 300.28 2138.43 
24 CP 299.93 298.55 -30.99 
31 CP 227.96 384.30 3517.56 
32 CP 89.88 391.18 6779.44 
38 CP 421.14 714.19 6593.49 
6 CPH 197.66 238.64 922.00 
17 CPH 283.75 361.57 1751.03 
19 CPH 214.19 312.67 2215.91 
20 CPH 209.75 263.77 1215.65 
23 CPH 528.24 648.07 2696.28 
30 CPH 200.07 390.84 4292.36 
36 CPH 272.38 737.60 10467.46 
1 CPHL 176.65 591.60 9336.26 
10 CPHL 370.87 428.03 1286.16 
18 CPHL 152.89 660.81 11428.20 
25 CPHL 235.19 625.34 8778.41 
27 CPHL 367.42 546.14 4021.18 
37 CPHL 397.38 524.45 2858.99 
42 CPHL 369.83 449.38 1789.77 
Plasma Insuln 
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Muscle glycogen concentration 
# of rats Treatment cont. (μg/100μl) mg/g muscle μmole/g muscle 
5 CON 4.80 4.01 22.26 
16 CON 2.49 1.86 10.33 
22 CON 4.46 3.22 17.87 
26 CON 4.50 3.53 19.59 
28 CON 4.89 3.57 19.79 
34 CON 4.76 3.08 17.11 
39 CON 3.70 2.93 16.28 
2 CHO 4.40 3.21 17.82 
3 CHO 4.57 3.09 17.13 
13 CHO 4.42 3.47 19.23 
15 CHO 5.65 3.78 20.95 
29 CHO 4.23 2.86 15.87 
33 CHO 4.82 3.29 18.28 
35 CHO 4.15 2.96 16.43 
4 CP 4.80 3.63 20.14 
14 CP 6.00 4.06 22.51 
21 CP 5.30 3.70 20.52 
24 CP 4.36 3.25 18.06 
31 CP 3.90 3.06 16.97 
32 CP 4.09 3.24 18.01 
38 CP 4.80 3.63 20.14 
6 CPH 3.52 2.35 13.05 
17 CPH 4.25 2.87 15.94 
19 CPH 4.86 3.77 20.90 
20 CPH 3.98 2.84 15.77 
23 CPH 6.76 4.67 25.90 
30 CPH 4.44 3.14 17.40 
36 CPH 4.57 3.58 19.88 
1 CPHL 5.28 3.46 19.17 
10 CPHL 4.69 3.28 18.18 
18 CPHL 4.67 3.19 17.71 
25 CPHL 5.49 3.88 21.51 
27 CPHL 4.53 3.30 18.33 
37 CPHL 5.63 3.80 21.10 







# of rats Treatment p-Akt/STD p-mTOR/STD p-AS160/STD 
5 CON 0.46 0.94 0.42 
16 CON 0.15 0.66 0.49 
22 CON 0.29 0.77 0.52 
26 CON 0.18 1.21 0.38 
28 CON 0.35 1.29 0.79 
34 CON 0.46 1.09 0.54 
39 CON 0.46 1.23 0.39 
2 CHO 0.28 0.70 0.28 
3 CHO 0.18 0.95 0.32 
13 CHO 0.44 0.75 0.59 
15 CHO 0.17 0.49 0.21 
29 CHO 0.52 1.23 0.38 
33 CHO 0.58 1.11 0.24 
35 CHO 0.54 1.08 0.57 
4 CP 0.36 0.87 0.70 
14 CP 0.55 0.61 0.31 
21 CP 0.36 0.91 0.61 
24 CP 0.24 1.03 0.54 
31 CP 0.28 1.14 0.53 
32 CP 0.14 0.86 0.59 
38 CP 0.56 1.05 1.19 
6 CPH 0.23 1.03 1.08 
17 CPH 0.22 0.64 0.30 
19 CPH 0.41 0.79 0.43 
20 CPH 0.23 0.71 0.31 
23 CPH 0.23 0.78 0.44 
30 CPH 0.45 0.61 0.56 
36 CPH 0.51 0.86 0.67 
1 CPHL 0.20 1.00 1.05 
10 CPHL 0.24 0.73 0.96 
18 CPHL 0.36 0.79 0.84 
25 CPHL 0.22 0.83 1.17 
27 CPHL 0.48 0.86 0.54 
37 CPHL 0.49 0.94 0.45 
42 CPHL 0.44 0.50 0.67 
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# of rats Treatment p-GSK3α/STD p-GSK3β/STD p-GS/STD α-tubulin/STD 
5 CON 0.88 0.69 1.01 4.28 
16 CON 0.50 0.49 0.88 7.69 
22 CON 0.47 0.43 0.47 3.32 
26 CON 0.64 0.58 1.35 2.06 
28 CON 0.90 1.52 0.82 3.19 
34 CON 1.04 1.62 0.72 2.87 
39 CON 0.70 1.03 0.58 2.35 
2 CHO 0.68 0.61 0.95 2.22 
3 CHO 0.59 0.62 0.67 4.02 
13 CHO 0.64 0.50 1.18 5.28 
15 CHO 0.53 0.47 0.66 4.22 
29 CHO 1.13 1.55 0.88 6.52 
33 CHO 1.11 1.55 0.65 1.67 
35 CHO 0.95 1.59 0.52 1.96 
4 CP 0.63 0.57 0.78 3.96 
14 CP 0.55 0.55 1.47 5.87 
21 CP 0.53 0.44 1.34 7.51 
24 CP 0.57 0.65 1.08 4.69 
31 CP 0.87 1.50 0.73 2.70 
32 CP 1.03 1.19 0.62 2.02 
38 CP 1.12 1.39 0.65 2.34 
6 CPH 0.85 0.63 1.19 7.29 
17 CPH 0.63 0.71 0.75 4.45 
19 CPH 0.59 0.58 1.19 4.03 
20 CPH 0.67 0.51 0.81 3.15 
23 CPH 0.57 0.49 1.34 5.48 
30 CPH 0.76 1.07 0.56 1.88 
36 CPH 1.16 1.45 0.50 2.70 
1 CPHL 0.80 0.71 1.22 5.41 
10 CPHL 0.59 0.52 1.37 7.42 
18 CPHL 0.65 0.55 1.09 4.97 
25 CPHL 0.60 0.59 1.32 4.95 
27 CPHL 1.19 2.08 1.02 3.26 
37 CPHL 1.24 1.90 0.80 2.60 
42 CPHL 0.74 1.02 0.49 2.16 
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